查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599301

虛擬臨床試驗市場：依研究設計，相關 - 全球預測 2025-2030

Virtual Clinical Trials Market by Study Design (Expanded Access Trials, Interventional Trials, Observational Trials), Implication (Cardiovascular Disease, Oncology) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年虛擬臨床試驗市場價值為38.1億美元，預計到2024年將達到46.6億美元，複合年成長率為22.44%，到2030年將達到157.2億美元。

虛擬臨床試驗 (VCT) 是臨床研究的一種創新方法，它透過支援遠端參與和資料收集的數位工具和平台來補充或取代臨床試驗的傳統方面。 VCT 的需求源於增加參與者多樣性、降低成本以及提高病患可及性和依從性的需要。它特別適用於藥物和治療方法開發的各個階段，其中以患者為中心的資料收集至關重要。主要最終用戶包括希望簡化業務並覆蓋更廣泛受眾的製藥公司、生物技術公司和受託研究機構。

主要市場統計
基準年[2023] 38.1億美元
預測年份 [2024] 46.6億美元
預測年份 [2030] 157.2億美元
複合年成長率（%） 22.44%

根據市場洞察，數位健康創新的激增和遠距遠端醫療接受度的提高正在顯著影響成長。穿戴式科技、人工智慧和機器學習的進步使 VCT 更有效率和個人化，為在臨床試驗中進一步整合真實世界證據提供了機會。企業正在透過投資先進的資料管理解決方案並確保遵守不斷變化的監管標準來利用這些進步。然而，也存在可能阻礙廣泛使用的限制，例如資料隱私問題、技術偏見和國際法規的差異。此外，一些地區基礎設施不發達，人口差異造成的數位落差也是一大問題。

業務成長的創新領域包括開發用於分散臨床試驗的安全平台、增強數位患者招募策略以及利用區塊鏈確保資料安全。關於人工智慧在預測分析和病患監測中的作用的研究也很有前景。市場動態的特點是技術快速進步，需要靈活的策略和夥伴關係來有效滲透市場。企業應專注於與高科技公司建立合作，以推動產品創新，並與監管機構合作，塑造有利於 VCT 的環境。總體而言，利用以患者為中心的創新，同時解決隱私和監管挑戰，對於虛擬臨床試驗的持續成長和成功至關重要。

市場動態：揭示快速發展的虛擬臨床試驗市場的關鍵市場洞察

虛擬臨床試驗市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大遠端醫療的採用
    • 醫療領域更採用數位化世界
    • 活性化研發活動並結合政府的有利支持
  • 市場限制因素
    • 對大規模資料採集、資料準確性和可靠性以及技術故障的擔憂
  • 市場機會
    • 將新技術融入臨床試驗
    • 在軟體、生物技術和臨床研究公司之間建立合作
  • 市場問題
    • 與受試者註冊和參與活動相關的複雜且困難的過程

波特五力：駕馭虛擬臨床試驗市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解虛擬臨床試驗市場的外部影響

外部宏觀環境因素在塑造虛擬臨床試驗市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過檢查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解虛擬臨床試驗市場的競爭格局

虛擬臨床試驗市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：虛擬臨床試驗市場供應商的績效評估

FPNV 定位矩陣是評估虛擬臨床試驗市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製虛擬臨床試驗市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對虛擬臨床試驗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章 關鍵測試方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 遠端醫療的採用率增加
      • 在醫療領域，數位化的採用正在全球擴大
      • 研發活動迅速增加和政府的有利支持
    • 抑制因素
      • 對大規模資料採集、資料準確性和可靠性以及技術故障的擔憂
    • 機會
      • 將新技術融入臨床試驗
      • 軟體、生物技術和臨床研究試驗公司之間的新合作
    • 任務
      • 與註冊和參與活動相關的繁瑣且困難的流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 虛擬臨床試驗市場：依研究設計

  • 介紹
  • 擴大訪問考試
  • 干預試驗
  • 觀察測試

第7章 虛擬臨床試驗市場：依相關性

  • 介紹
  • 心血管疾病
  • 瘤

第8章美洲虛擬臨床試驗市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太虛擬臨床試驗市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的虛擬臨床試驗市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AiCure, LLC
  • Clinical Ink, Inc. by GI Partners
  • CliniOps, Inc
  • Everest Global, Inc
  • ICON PLC
  • IQVIA Inc.
  • Medable, Inc.
  • Medidata Solutions by Dassault Systemes SE
  • Medpace, Inc.
  • MedPoint Digital, Inc.
  • Navitas Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Pfizer Inc.
  • VirTrial, LLC by Signant Health
Product Code: MRR-A339DAEFA4E6

The Virtual Clinical Trials Market was valued at USD 3.81 billion in 2023, expected to reach USD 4.66 billion in 2024, and is projected to grow at a CAGR of 22.44%, to USD 15.72 billion by 2030.

Virtual clinical trials (VCTs) are innovative approaches in clinical research where the traditional aspects of trial conduction are complemented or replaced by digital tools and platforms, enabling remote participation and data collection. The necessity for VCTs arises from the need to enhance participant diversity, reduce costs, and improve patient accessibility and compliance, especially pertinent during global events like pandemics where physical distancing is vital. They find application in numerous phases of drug and therapy development, particularly where patient-centric data collection is paramount. Key end-users include pharmaceutical companies, biotechnology firms, and contract research organizations aiming to streamline operations and reach broader demographics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.81 billion
Estimated Year [2024] USD 4.66 billion
Forecast Year [2030] USD 15.72 billion
CAGR (%) 22.44%

Market insights reveal a surge in digital health innovations and an increasing acceptance of telemedicine, significantly influencing growth. Factors such as advancements in wearable technology, AI, and machine learning are driving efficiencies and personalization in VCTs, opening up opportunities for further integration of real-world evidence in research. Companies are capitalizing on these advancements by investing in sophisticated data management solutions and ensuring compliance with evolving regulatory standards. However, limitations include data privacy concerns, technological biases, and varying international regulations that could hinder widespread adoption. The lack of infrastructure in certain regions and the digital divide between different demographic groups pose significant challenges.

For business growth, areas of innovation include development of secure platforms for decentralized trials, enhancement of digital patient recruitment strategies, and leveraging blockchain for data security. Research into AI's role in predictive analytics and patient monitoring is also promising. Market dynamics are characterized by rapid technological advancements, which necessitate agile strategies and partnerships for effective market penetration. Companies should focus on forging collaborations with tech firms to drive product innovation, and engage with regulatory bodies to shape favorable landscapes for VCTs. Overall, tapping into patient-centric innovations while addressing privacy and regulatory challenges will be crucial for the sustained growth and success of virtual clinical trials.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Virtual Clinical Trials Market

The Virtual Clinical Trials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of telehealth
    • Growing adoption of digitization in healthcare sector globally
    • Proliferation in research and development activities coupled with favorable government support
  • Market Restraints
    • Concerns over large data collection, data accuracy and reliability, and technological failure
  • Market Opportunities
    • Integration of new technologies in clinical trials
    • Emerging collaborations between software, biotechnology and clinical research companies
  • Market Challenges
    • Cumbersome and difficult process with enrolment and engagement activities

Porter's Five Forces: A Strategic Tool for Navigating the Virtual Clinical Trials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Virtual Clinical Trials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Virtual Clinical Trials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Virtual Clinical Trials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Virtual Clinical Trials Market

A detailed market share analysis in the Virtual Clinical Trials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Virtual Clinical Trials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Virtual Clinical Trials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Virtual Clinical Trials Market

A strategic analysis of the Virtual Clinical Trials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Virtual Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Clinical Ink, Inc. by GI Partners, CliniOps, Inc, Everest Global, Inc, ICON PLC, IQVIA Inc., Medable, Inc., Medidata Solutions by Dassault Systemes S.E., Medpace, Inc., MedPoint Digital, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Pfizer Inc., and VirTrial, LLC by Signant Health.

Market Segmentation & Coverage

This research report categorizes the Virtual Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Study Design, market is studied across Expanded Access Trials, Interventional Trials, and Observational Trials.
  • Based on Implication, market is studied across Cardiovascular Disease and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of telehealth
      • 5.1.1.2. Growing adoption of digitization in healthcare sector globally
      • 5.1.1.3. Proliferation in research and development activities coupled with favorable government support
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over large data collection, data accuracy and reliability, and technological failure
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of new technologies in clinical trials
      • 5.1.3.2. Emerging collaborations between software, biotechnology and clinical research companies
    • 5.1.4. Challenges
      • 5.1.4.1. Cumbersome and difficult process with enrolment and engagement activities
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Virtual Clinical Trials Market, by Study Design

  • 6.1. Introduction
  • 6.2. Expanded Access Trials
  • 6.3. Interventional Trials
  • 6.4. Observational Trials

7. Virtual Clinical Trials Market, by Implication

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Oncology

8. Americas Virtual Clinical Trials Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Virtual Clinical Trials Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Virtual Clinical Trials Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AiCure, LLC
  • 2. Clinical Ink, Inc. by GI Partners
  • 3. CliniOps, Inc
  • 4. Everest Global, Inc
  • 5. ICON PLC
  • 6. IQVIA Inc.
  • 7. Medable, Inc.
  • 8. Medidata Solutions by Dassault Systemes S.E.
  • 9. Medpace, Inc.
  • 10. MedPoint Digital, Inc.
  • 11. Navitas Inc.
  • 12. Oracle Corporation
  • 13. Parexel International Corporation
  • 14. Pfizer Inc.
  • 15. VirTrial, LLC by Signant Health

LIST OF FIGURES

  • FIGURE 1. VIRTUAL CLINICAL TRIALS MARKET RESEARCH PROCESS
  • FIGURE 2. VIRTUAL CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VIRTUAL CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VIRTUAL CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VIRTUAL CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VIRTUAL CLINICAL TRIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIRTUAL CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. VIRTUAL CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023